CYTO (Altamira Therapeutics Ltd) Bozor qiymatining balans qiymatiga nisbati

altamiratherapeutics.com (CYTO) kompaniyasining rasmiy ramzlari

Altamira Therapeutics o'smalarda RNA ning maqsadli transporti uchun innovatsion OligoPhore tizimini ishlab chiqmoqda. Shu bilan birga, kompaniya o'pka patologiyalari uchun inhalatsiya terapiyalarini yaratmoqda. GURU.Markets grafigidagi kompaniyaning bozor kapitalizatsiyasining uning balans qiymatiga nisbati ushbu ko'rsatkich 0.13 ga teng ekanligini ko'rsatadi. B2B hamkorlarining CYTO brendi sifatiga bo'lgan yuqori ishonchi uzoq muddatli o'sish uchun ijobiy drayver bo'lib xizmat qiladi.

CYTO altamiratherapeutics.com: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 21.12.2024 oraligʻida

Altamira Therapeutics (CYTO) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi altamiratherapeutics.com|CYTO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Auris Medical|CYTO - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Altamira Therapeutics|CYTO - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati altamiratherapeutics.com|CYTO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Altamira Therapeutics|CYTO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati altamiratherapeutics.com|CYTO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Auris Medical
Kompaniyaning dastlabki tahlili:Altamira Therapeutics Ltd - CYTO
altamiratherapeutics.com original mahsuloti

Ushbu ko'rsatkich biznesning haddan tashqari qimmat yoki arzon baholanganini aniqlash uchun aksiyalarning bozor qiymatini sof aktivlar bilan solishtiradi. Metrika joriy kapitalga nisbatan bozor kelajakdagi o'sish uchun qancha premium to'lashga tayyorligini belgilaydi. Bozor qiymatining buxgalteriya qiymatiga nisbatini tahlil qilish haddan tashqari qizigan aktivlarni sotib olishdan qochishga yordam beradi. Altamira Therapeutics (CYTO) uchun ushbu farq intellektual kapitalning qiymatini aks ettiradi. Investorlar patentlarning salohiyatini va molekulyar olimlarning noyob tajribasini narxga kiritmoqdalar.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati HLN|KVUE (kenvue.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati enterabio.com (ENTX)|Bozor kapitallashuvining balans qiymatiga nisbati HYFT (MindWalk Holdings Inc.)|ABVC BioPharma Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|CPIX - Bozor qiymatining balans qiymatiga nisbati|Quantum BioPharma Corp (QNTM) - Bozor qiymatining balans qiymatiga nisbati|FGEN - Kapitallashuvning sof aktivlarga nisbati|telomirpharma.com (TELO) - Bozor kapitallashuvining balans qiymatiga multiplikatori|RANI (Rani Therapeutics Holdings) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SNYR|Bozor qiymatining balans qiymatiga nisbati RLYB (Rallybio Corporation)|Kapitallashuvning sof aktivlarga nisbati lexariabioscience.com (LEXX)|Bozor kapitallashuvining balans qiymatiga nisbati PULM|Pheton Holdings Limited - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Aptorum (APM)|LYRA - Balans qiymatiga nisbatan bozor qiymati|IBO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TNF Pharmaceuticals, Inc.|YCBD - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati painreform.com (PRFX)|Kapitallashuvning sof aktivlarga nisbati Lipella Pharmaceuticals, Inc.|Bozor kapitallashuvining balans qiymatiga multiplikatori OptiNose Inc (OPTN)|Bozor kapitallashuvining balans qiymatiga nisbati Pieris|Balans qiymatiga nisbatan bozor qiymati Procaps Group Corp PROC|PTPI (Petros Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|QLI: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati ACELYRIN SLRN|TFF Pharmaceuticals Inc. (TFFP) - Balans qiymatiga nisbatan bozor qiymati